ABHD2 and hepatocellular carcinoma: Elevated-ABHD2 catalyzes the metabolic process of TG to FFAs, thus promoting the β-oxidation pathway and increasing the production of ROS, finally resulting in the suppression of apoptosis and facilitation of proliferation in HCC.